SUBSTIPHARM
Elise Bastian has extensive experience in regulatory affairs spanning over 16 years, currently serving as a Senior Regulatory Affairs & CMC Manager in the Development department at SUBSTIPHARM since April 2009. Elise has held multiple roles at SUBSTIPHARM, including US Regulatory Affairs Manager and EU & International Regulatory Affairs Project Manager. Prior to this, Elise worked as a Regulatory Executive on the International Regulatory Affairs Oncology team at GlaxoSmithKline and completed an industrial student placement in European Regulatory Affairs at Ipsen. Academic qualifications include a Master's degree in Drug Development and International Registration from Université Paris XI and an Engineer's Master's degree in Industrial Biology with a specialty in Product Development from École de Biologie Industrielle.
SUBSTIPHARM
Substipharm is a privately held pharmaceutical Group. We develop, supply and commercialize pharmaceuticals in more than 60 countries worldwide. Our portfolio of products that we currently license out or distribute directly or through partners comprises more than 60 different molecules. Our development pipeline includes as well more than 40 ongoing projects. We have a successful portfolio of pharmaceutical products and vaccines including: Mature brands Generics Over the counter (OTC) pharmaceuticals Difficult to develop medicines Value added presentations Biological products including vaccines: